Webinar Summary

With the increasing use of 3D cell structures for modeling tumors, organs, and tissue for translation research, there is a requirement for cancer models, assays and workflows to study patient-derived samples. In this webinar the speakers will present efforts of a successful collaboration of using our automated assay system (the Pu·MA System) with patient-derived organoids for developing an efficient workflow which was incorporated into a translational project which addressed therapeutics and drug resistance in triple negative breast cancer.

Presenters

• Margarite Matossian, MD PhD (Tulane University Medical University) Physician-Scientist in the group of Dr. Matthew Burow (Burow Lab). This study was funded by NIH & Krewe de Pink) Patient-Derived Organoids: Translational Oncology research to Interrogate Therapeutic Responses & Drug Resistance
• Katya Nikolov, MD (Protein Fluidics, Inc.) Senior Application Scientist Automated Assays with Patient-Derived Organoids using the Pu·MA System